- ►diabetesjournals.org EA Ryan, BW Paty, PA Senior, D Bigam, E … - Diabetes, 2005 - Am Diabetes Assoc Islet transplantation can restore endogenous β-cell function to subjects with
type 1 diabetes. Sixty-five patients received an islet transplant in Edmonton as
of 1 November 2004. Their mean age was 42.9 ± 1.2 years, their mean ... Cited by 530 - Related articles - All 10 versions
- ►diabetesresearch.org [PDF] T Froud, C Ricordi, DA Baidal, MM Hafiz, G … - American Journal of Transplantation, 2005 - ccmjournal.org T he appropriate management of fluids, including the use of colloid therapy, in
patients with acute lung injury (ALI) and acute respiratory distress syndrome
(ARDS) has been debated for decades and remains controversial (1). The case ... Cited by 140 - Related articles - All 8 versions
- ►nih.gov KI Rother, DM Harlan - Journal of Clinical Investigation, 2004 - Am Soc Clin Investig Worldwide, more than 750 individuals with type 1 diabetes mellitus (T1DM) have
received allogeneic islet transplants since 1974, in an effort to cure their
chronic condition. Though this is still a small number (especially when ... Cited by 103 - Related articles - BL Direct - All 11 versions
A Pileggi, C Ricordi, NS Kenyon, T Froud, DA … - Transplantation - diabetesresearch.org Intensive insulin therapy with the goal of maintain- ing blood glucose
concentrations close to the normal range can delay or prevent the onset of
diabetes compli- cations in patients with type 1 diabetes mellitus ... Cited by 24 - Related articles - View as HTML - BL Direct - All 2 versions
A Pileggi, R Alejandro, C Ricordi - Current Opinion in Organ Transplantation, 2006 - journals.lww.com Purpose of review Clinical islet transplantation has evolved rapidly in recent
years and current clinical trials are showing the benefits of this therapeutic
approach for patients with diabetes. New challenges are emerging and must ... Cited by 14 - Related articles - BL Direct - All 3 versions
E Estella, MD McKenzie, T Catterall, VR … - Diabetes, 2006 - Am Diabetes Assoc Perforin-deficient NOD mice are protected from diabetes, suggesting that
cytotoxic granule contents of CD8 + T-cells have a significant role in killing
β-cells. Despite this, cytotoxic granule effects on human or mouse ... Cited by 13 - Related articles - BL Direct - All 4 versions
A PILEGGI, L COBIANCHI, L INVERARDI, C … - Annals of the New York Academy of Sciences, 2006 - cat.inist.fr Steady improvements in islet cell processing technology and immunosuppressive
protocols have made pancreatic islet transplantation a clinical reality for the
treatment of patients with Type diabetes mellitus(T 1 DM). Recent trials ... Cited by 13 - Related articles - BL Direct - All 5 versions
- ►diabetesresearch.org [PDF] T Froud, RN Faradji, A Pileggi, S Messinger, … - Transplantation, 2008 - journals.lww.com Tatiana Froud,1,2,3 Raquel N. Faradji,1,4 Antonello Pileggi,1,3 Shari
Messinger,1,5 David A. Baidal,1 Gaston M. Ponte,1 Pablo E. Cure,1 Kathy Monroy,1
Armando Mendez,1,4 Gennaro Selvaggi,1,3 Camillo Ricordi,1,3 and Rodolfo ... Cited by 12 - Related articles - All 5 versions
- ►prsjournal.net D Mineo, C Ricordi, X Xu, A Pileggi, R Garcia … - American Journal of Transplantation, 2008 - prsjournal.net To prevent graft rejection and avoid immunosuppression-related side-effects, we
attempted to induce recipient chimerism and graft tolerance in islet
transplantation by donor CD34+hematopoietic stem cell (HSC) infusion. Six ... Cited by 11 - Related articles - Cached - BL Direct - All 6 versions
- ►diabetesresearch.org [PDF] R Cardani, A Pileggi, C Ricordi, C Gomez, DA … - Transplantation, 2007 - journals.lww.com Roberta Cardani,1,2 Antonello Pileggi,1,3 Camillo Ricordi,1,3 Carmen Gomez,3,4
David A. Baidal,1 Gaston G. Ponte,1 Davide Mineo,1 Raquel N. Faradji,1,5 Tatiana
Froud,1,6 Gaetano Ciancio,3,7,8 Violet Esquenazi,3,4 George W. Burke ... Cited by 8 - Related articles - BL Direct - All 5 versions
